Evidence map›Paper›PMID 19564302›Full record

ArticlePediatrics2009

Intravenous lipid and bilirubin-albumin binding variables in premature infants.

Sanjiv B Amin, Theresa Harte, Lori Scholer, Hongyue Wang

Abstract read
In one paragraph

Article in Pediatrics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Unbound bilirubin measurements by a novel probe in preterm infants.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2019
    Article
  10. Article
  11. Review
  12. Neonatal pharmacology: extensive interindividual variability despite limited size.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2011
    Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sanjiv B AminDivision of Neonatology, Department of Pediatrics, University of Rochester School of Medicine, Rochester, New York 14642, USA. sanjiv_amin@urmc.rochester.edu
Theresa Harte
Lori Scholer
Hongyue Wang
Pediatrics and Genetics · USUniversity of Rochester · US

Funding

UNIVERSITY OF ROCHESTER'S RESEARCH ASSOCIATE ORGANIZATIONUL1RR024160 · NCRR · UNIVERSITY OF ROCHESTER · PI PEARSON, THOMAS ARTHUR · 2006 to 2011
$38.7M
Bilirubin-induced Auditory Neuropathy in PretermsK23DC006229 · NIDCD · UNIVERSITY OF ROCHESTER · PI AMIN, SANJIV B · 2004 to 2008
$966k
NCRR NIH HHS UL1 RR 024160NCRR NIH HHS UL1 RR024160NIDCD NIH HHS K23 DC006229NIDCD NIH HHS K-23DC 006229-02
6 · The paper itself

Abstract

backgroundThe lipid intake at which a significant bilirubin-displacing effect occurs as a function of gestational age (GA) is unclear.

objectiveTo determine the effect of gradual increase in IL intake from 1.5 to 3 g/kg per day on bilirubin-albumin binding variables as a function of GA in premature infants with indirect hyperbilirubinemia.

methodsInfants of 24 to 33 weeks' gestation at birth who received IL (20% Intralipid [Fresenius Kabi, Uppsala, Sweden]) doses of 1.5, 2, 2.5, and 3 g/kg per day over 4 consecutive days were prospectively evaluated. The blood samples were drawn twice at least 8 hours apart on each IL intake to measure total serum bilirubin and free bilirubin by the peroxidase test. The highest free bilirubin on each IL intake, the corresponding total serum bilirubin, and serum albumin were used to calculate the bilirubin/albumin binding constant or binding affinity.

resultsSixty-two infants (median GA: 28 weeks) were studied during the first 10 days of life. None of the subjects had culture-proven sepsis, had triglyceride levels of >2.05 mmol/L, or were receiving steroids. Infants were grouped in 2-week GA intervals. The cumulative frequency of elevated free bilirubin concentration (>or=90th percentile or B(f) >or= 32 nmol/L) as a function of IL intake was inversely related to GA and was significantly different among 2-week GA groups. There was significant decrease in binding affinity and increase in free bilirubin concentration with higher IL intake for <or=28 week but not for >28 week GA groups.

conclusionsThe IL intake may be associated with a significant fall in the binding affinity of bilirubin for plasma protein and a concomitant increase in free bilirubin concentration in premature infants. The lipid intake at which this occurs depends on GA.

Indexed as

BilirubinFat Emulsions, IntravenousGestational AgeHumansHyperbilirubinemia, NeonatalInfant, NewbornInfant, PrematureProspective StudiesBilirubinFat Emulsions, Intravenous

Identifiers

PMID19564302
PMCPMC4285415
OpenAlexW2133000202

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.